SoundHealth, a San Francisco, CA-based medical technology company raised $7M in Seed funding.
The round was led by Moai Capital and J4 Ventures with participation from TeleSoft Partners, Tau Ventures, TechU Ventures and Rhythm Venture Capital.
Peter Moran, an early-stage investor in digital health and wellness companies, a former long-time managing partner at DCM Ventures, and a seed investor in SoundHealth, will join the SoundHealth board of directors.
The company intends to use the funds to enhance the commercialization and marketing of SONU and to seek regulatory authorization for additional indications for pediatric use and insomnia.
Led by founder and CEO Dr. Paramesh Gopi, SoundHealth is a medical technology company combining artificial intelligence and medical science to improve respiratory health. It provides SONU, which is an AI-enabled patented drug-free medical device that uses acoustic vibrational energy to provide personalized relief for nasal congestion. Acoustic vibration associated with humming has been shown to decrease symptoms of nasal congestion, possibly through modulation of autonomic inputs to the nasal mucosa or through nitric oxide activity, which may in turn exert a decongestant and anti-inflammatory effect on the nasal passages.
Using its proprietary AI technology, the SONU app scans their face using a smartphone, creates a digital map of their sinuses and calculates their optimal resonant frequencies. Following the initial one-time scan, the patient places the SONU band around their head, turns it on and the SONU band delivers frequencies tailored to the patient based on the app’s calculations.
FinSMEs
24/07/2024